Human Capital Advisors is launching a new campaign focusing on what we truly believe in... The Power of People . We will be highlighting those individuals or groups who have made a difference in their community and those they serve. If you have anyone who you would like to recommend as a feature please reach out!

There’s an old proverb that tells a story of a man walking along a beach completely covered by starfish that have been washed up on the shore due to a violent storm. He sees a little boy off in the distance picking them up one by one and throwing them back into the sea. The man approaches the child and says son what are you doing? You’ll never be able to throw them all back - it won’t make a difference! The little boy pauses for a moment and looks at the starfish in his hand. Then looks at the gentleman and says - it will to this one - and heaves the starfish into the waves. And as the gentleman continues to walk away he watches as the little boy continues to save as many as he can. 

Have you ever wondered why equally talented units have different results? Teams, companies, schools, and yet one always seems to outperform the others. Have you ever been inspired hearing of an individual or group or company that consistently makes a difference.  Research has shown over and over again that there is one common denominator- the people at the center. In the midst of the average, others stand out. A little extra time, a little extra effort, the conscious effort to always do one bit more. Those individuals make all the difference to teams, companies and organizations. That’s the Power of People Realized . Over the next several months we will be highlighting people who consistently make a difference. We welcome your thoughts and contributions as we continue to recognize those people around us who make a difference!
Our v ision  is to see a world free of dementia.

Our m ission  is to fund the discovery of breakthrough drugs and novel treatments to eliminate dementia.

Our guiding creed:  Funding  is our barrier.  Awareness  is our opportunity.  Research  is our salvation.  Time  is our enemy.  YOU  are our hope .
Join Clear Thoughts Foundation in their funding to fight dementia to ensure there isn't another family who will lose a loved one, a business man who will lose his career, or a brave soldier now lost and scared.
Clear Thoughts Foundation (CTF),  established in 2010, is a nonprofit organization located in Pittsburgh, Pennsylvania. Our primary purpose is to raise funds to discover breakthrough drugs and novel treatments to stop the progression of dementia and eventually eliminate this terrible disease. 

Clear Thoughts Foundation has pledged to take a stand in funding research to fight against all forms of dementia in contrast to the majority of charitable causes that focus their efforts on targeting a specific dementia disease. While many philanthropic organizations give support for basic research into the causes of the disease, few focus on both breakthrough drug discovery and development of novel treatments (bio-genetics, stem cells, etc.)
As CTF approaches their 10th year as a foundation, continued growth and pursuit of results has inspired the launch of a new fundraising initiative that aims to expand and enhance the breadth of their research efforts, as well as deepen the impact of their donor's support. The CTF Consortium is a collaborative group of renowned doctors and researchers working in Pittsburgh to cure dementia! Comprised of top researchers and doctors from UPMC and University of Pittsburgh; Dr. Robert Friedlander, Dr. Oscar Lopez, and Dr. Amantha Thathiah, this newly-funded initiative is set to allocate $150,000 in 2020 towards direct dementia research and collaborative discoveries.

   Chairman of the University of Pittsburgh Department of Neurological Surgery and co-director of the UPMC Neurological Institute.

Dr. Friedlander’s major research interests lie in the study of the mechanistic pathways of the caspase apoptosis gene family (cell death). His work includes the evaluation of treatment strategies for neurodegenerative diseases (Huntington’s and ALS), stroke, brain trauma, and spinal cord injury through the modulation of the caspase-family apoptotic pathways.

Funded research:  The research will focus on synthesis of melatonin in the brain and if the natural decline in melatonin synthesis with age contributes to age-related neurodegeneration. He believes a breakthrough in this regard would lead to the establishment of a mouse model of age-related neurodegeneration with a future goal to use this model to identify new strategies for preventing neuro-degenerative diseases, such as dementia.

Director of University of Pittsburgh Alzheimer’s Disease Research Center
Lopez is the principal investigator of 3 NIH-funded grants, and he is co-investigator in another 6 NIH-funded projects.

Funded research:  The research will focus on plasmapheresis (the removal, treatment and return or exchange of blood components) in mice. To date there are no animal models, although it was previously tested in his trial with human subjects with a proven 66% success rate of stopping the progression of Alzheimer’s disease, and in some cases, even improvement; however, the “why” is still unknown. A breakthrough in these results will have implications on the optimal dosage and frequency of the treatment in humans, providing proper treatment as it relates to the varying disease stages.

 Assistant Professor of Neurobiology at the University of Pittsburgh School of Medicine, Researcher at Pittsburgh Institute of Neurodegenerative Diseases (PIND)

Funded research:  The research will focus on new discoveries made relating to the mechanistic pathways of G Protein-Coupled receptors and their direct correlation to Alzheimer’s disease. Further discoveries to this relationship will work toward developing therapeutic intervention strategies to treat Alzheimer’s disease and other related dementias.

Thathiah has been the recipient of the Cornelli Young Investigator Award for research in Alzheimer’s Disease and the Memory Loss in Alzheimer’s Disease (MEMOSAD) Award.

Hayley D. Jameson  - Founder and President
Matthew Jameson  – Co-founder and Board Member
Sharon Sippel  – Co-founder and Emeritus

Roll for a Reason Gala  –  On Saturday, November 2 nd  2019, Clear Thoughts Foundation held its 6 th  annual Roll for a Reason Gala at J. Verno Studios in the South Side. Chris Mueller of  The Fan  was our wonderful Emcee, leading over 400 people in attendance who helped raise $175,000 for our mission to fund dementia research. Guests enjoyed casino gaming with new additions such as horse racing; silent, Chinese, and live auctions: including paintings of Elton John and Pittsburgh by George Williams of  Art Madness,  as well as a signed Paul McCartney Bass guitar; fantastic food by Heavenly Cuisine, amazing desserts from Pittsburgh Sweet Treats, and more! This year’s gala theme, ‘Rise Up,’ was inspired by the foundations new initiative and efforts to take immediate action with the hopes to offset the staggering statistics of dementia, as they believe their time to ‘rise up’ and end this disease is now. “ We need to act faster, raise more money, and proceed with relentless passion in this fight against dementia. We need to do better. We need to RISE UP!!”Founder and President, Hayley D. Jameson
Save the date and plan to join CTF next year for their largest fundraiser of the year to continue funding the fight against dementia - November 7th, 2020!
Human Capital Advisors applauds the Clear Thoughts Foundation for making a difference in our communities and providing the chance for a better life and to fund research to eradicate a disease that affects so many of our loved ones. What this organization accomplishes truly represents our belief in the power of people.

If you would like to learn more about what they do and how you can help please head to their website linked below!